Aflibercept is a vascular epidermal growth factor (VEGF-A and PlGF) receptor inhibitor that inhibits the growth of neovascularization. It can be used to study a variety of diseases caused by ocular neovascularization.
Molecular Weight:
96896.92
Purity:
>98%
CAS Number:
[862111-32-8]
Formula:
C4318H6788N1164O1304S32
Target:
VEGFR/PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted